January 8, 2019

Announcement no. 1

 

Corrected Financial Calendar 2019

DATE 2019DESCRIPTION

January 25, 2019
Quiet Period prior to the Annual Report begins (4 weeks)
February 1, 2019Deadline for shareholder proposals - Annual General Meeting
February 22, 2019Annual Report 2018 & Investor Meeting
March 18, 2019Annual General Meeting
April 25, 2019Quiet Period prior to the Interim Report begins (2 weeks)
May 9, 2019Interim Report – 3 months 2019 & Investor Meeting
August 1, 2019Quiet Period prior to the Interim Report begins (2 weeks)
August 15, 2019Interim Report – 6 months 2019 & Investor Meeting
October 24, 2019Quiet Period prior to the Interim Report begins (2 weeks)
November 7, 2019Interim Report – 9 months 2019 & Investor Meeting

 

For further information, please contact:
Gry Husby Larsen, General Counsel
Telephone +45 4529 0000, e-mail investor@bioporto.com

 

About BioPorto
BioPorto is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. BioPorto has its headquarters in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange.

 

Attachment